Skip to content
healthcare.dev

ALECENSA

NDC 50242-130, ALECTINIB HYDROCHLORIDE, capsule, from Genentech, Inc..

Product NDC
50242-130
Status
Listed
Labeler
Genentech, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208434
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALECTINIB HYDROCHLORIDE150 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]

Package NDCNDC-11Package
50242-130-01502420130011 BOTTLE, PLASTIC in 1 CARTON (50242-130-01) / 240 CAPSULE in 1 BOTTLE, PLASTIC
50242-130-86502420130861 BOTTLE, PLASTIC in 1 CARTON (50242-130-86) / 240 CAPSULE in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/42c49deb-713b-427a-9670-08af08adcffb

Use it

Look up 50242-130 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-130 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.